ALLEREX

This brand name is authorized in Nigeria

Active ingredients

The drug ALLEREX contains a combination of these active pharmaceutical ingredients (APIs):

1 Antazoline
UNII FP8Q8F72JH - ANTAZOLINE HYDROCHLORIDE

Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.

Read about Antazoline
2 Tetryzoline
UNII 0YZT43HS7D - TETRAHYDROZOLINE HYDROCHLORIDE

Tetryzoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray for decongestion of nasal and nasopharyngeal mucosa.

Read about Tetryzoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01GA52 Tetryzoline, combinations S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GA Sympathomimetics used as decongestants
Discover more medicines within S01GA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: NG Registered Drug Product Database Identifier(s): 04-3534

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.